About DermaClip US

DermaClip US, LLC is a Houston-based medical device company focused on advancing needle-free wound closure for clinical and tactical environments. Our flagship product, DermaClip, was developed to address a persistent gap in closure technology — a method that achieves the anatomical gold standard of wound eversion without the procedural burden of sutures or the limitations of tissue adhesives.

The Science, Validated

DermaClip's clinical foundation is established through four peer-reviewed publications spanning military trauma, emergency medicine, obstetrics, and surgical settings.

A randomized controlled trial published in Military Medicine (2018) demonstrated 100% Level 1 healing in 120 patients. A prospective study presented at SOMA 2025 at Darnall Army Medical Center showed 83% faster closure than sutures. A case report published in Case Reports in Emergency Medicine validated use on skin tears in fragile elderly patients. A study published in the Journal of Reproductive Medicine (2019) demonstrated 53% faster closure in C-section patients.

The device has been adopted by MARSOC and is distributed through major healthcare distributors including McKesson, Henry Schein, and Owens & Minor.

Review the Clinical Evidence

The Team

Jeffrey S. Freed, MD, FACS, FACG

Chief Medical Officer Chairman, Medical Advisory Board

Dr. Freed specializes in colon and rectal surgery with 45 years of experience in the field. He is a Clinical Professor of Surgery at the Icahn School of Medicine at Mount Sinai in New York and is affiliated with the VA system. Dr. Freed serves as Chairman of DermaClip's Medical Advisory Board and guides the company's clinical development strategy.

John Ko, MD, PhD, FACS

Member, Medical Advisory Board

Dr. Ko specializes in Plastic and Reconstructive Surgery. He is Assistant Clinical Professor of Surgery at the Icahn School of Medicine at Mount Sinai in New York. Dr. Ko brings expertise in reconstructive techniques and wound healing to DermaClip's Medical Advisory Board.

Management

Charles M. Darling, IV
President & CEO
Mr. Darling has been involved in project development and investment for over 30 years. Previously, he was President, General Counsel and Director of a publicly traded energy company, of which he was a founder and helped foster its growth from a start-up to a publicly-traded holding company with two publicly-traded subsidiaries that he subsequently helped manage the sale of to a major energy company.
Catherine Fonfara
Senior Vice President, Finance & Legal
Ms. Fonfara worked in the legal area for 30 years, the last 12 of which were with Baker Botts, LLP. Prior to that she worked for a Prince of the Kingdom of Saudi Arabia, assisting him in his duties with the United Nations in Third-World countries.
Christopher Darling
COO, Head of Business Development
Mr. Darling brings over 10 years of experience in medical device commercialization, business development, and operations. He holds an MBA from the Wharton School at the University of Pennsylvania. Prior to DermaClip, he worked in investment banking at BNP Paribas in London and in management consulting at Deloitte. He currently leads sales strategy, digital operations, and distributor relationships for DermaClip US.